Cannabis-Related Federal Legislation (2019)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
DEVELOPING LOCAL CANNABIS POLICY in MASSACHUSETTS a Primer for Elected Leaders and Staff Across the Commonwealth
DEVELOPING LOCAL CANNABIS POLICY IN MASSACHUSETTS A Primer for Elected Leaders and Staff Across the Commonwealth JUNE 2018 Contents Introduction ....................................................................................................................................... 2 About Weedmaps .............................................................................................................................. 3 Section 1. A History of Cannabis Legalization in the United States ..................................................... 4 Section 2. A History of Cannabis Legalization in Massachusetts ......................................................... 7 Section 3. Massachusetts’ Adult-Use Cannabis Policy Timeline: Key Dates and Deadlines ................. 8 Section 4. Overview of State-Level Cannabis Policy ........................................................................... 9 Section 5. Massachusetts State Agencies Working on Cannabis Policy ........................................... 12 Section 6. Economic Impact & Tax Revenue ..................................................................................... 14 Section 7. Massachusetts License Types, Economic Impact, and Tax Revenue ................................. 16 Section 8: Authority of Local Governments ...................................................................................... 20 Local Cannabis Policy Checklist ...................................................................................................... 22 Section 9: Local Government Considerations -
The Green Regulatory Arbitrage
Table of Contents I. EXECUTIVE SUMMARY ...................................................................................................... 1 II. PROHIBITION - HOW CANNABIS BECAME ILLEGAL ..................................................... 4 III. THE LEGAL LANDSCAPE .................................................................................................... 7 A. Federal Law And Its Impact On The Cannabis Industry ..................................................... 7 1. Cannabis Is A Schedule 1 Substance ............................................................................ 7 2. Access To Capital Markets Restricted ......................................................................... 9 3. Banking Services Limited .......................................................................................... 10 4. Tax Burdens .............................................................................................................. 11 5. Interstate And International Commerce Restrictions ................................................. 11 6. Insurance Options Limited ........................................................................................ 12 7. Medical Research And Clinical Trials Stymied .......................................................... 12 8. Professional Services Harder To Find ........................................................................ 13 9. Real Estate Challenges .............................................................................................. 13 B. The States -
Unconstitutional Qualification of the Right to Bear Arms by the Federal Government Against Law-Abiding Medical Marijuana Patients
A STICKY SITUATION: THE UNCONSTITUTIONAL QUALIFICATION OF THE RIGHT TO BEAR ARMS BY THE FEDERAL GOVERNMENT AGAINST LAW-ABIDING MEDICAL MARIJUANA PATIENTS LUKE C. WATERS* INTRODUCTION ......................................................................................... 116 I. MEDICAL MARIJUANA LAWS ................................................................ 120 A. Comprehensive Medical Marijuana Programs ....................... 121 B. Federal Laws & Policies ........................................................ 129 1. The Ogden Memo ............................................................. 134 2. The Cole Memo ................................................................ 135 3. The Cole Recreational Memo ........................................... 137 4. The Sessions Enforcement Memo .................................... 137 5. The Rohrabacher-Farr Amendment .................................. 138 II. SECOND AMENDMENT RIGHTS ............................................................ 142 A. An Awkward Landmark Decision ......................................... 143 B. The Post-Heller Two-Step Qualification Analysis ................ 144 1. Individuals Adjudicated as Mentally-Ill ........................... 149 2. Users of Illegal Drugs ....................................................... 151 IV. UNCONSTITUTIONAL APPLICATION ................................................... 152 A. Modest Collateral Burdens: Wilson v. Lynch ......................... 153 B. Applying the Two-Step Test to Qualified Patients Appropriately -
Rethinking Federal Marijuana Policy by Ed Chung, Maritza Perez, and Lea Hunter May 1, 2018
Rethinking Federal Marijuana Policy By Ed Chung, Maritza Perez, and Lea Hunter May 1, 2018 For decades, the failed war on drugs has devastated communities across the United States, contributing to unprecedented rates of incarceration. The United States has nearly 25 percent of the world’s incarcerated population despite comprising less than 5 percent of the world’s total population.1 This phenomenon gained momentum in the 1970s when President Richard Nixon first declared a war on drugs and policy- makers at all levels of government added harsh criminal penalties for drug offenses, leading to explosive incarceration rates. Since then, the nation’s incarcerated popula- tion has increased sevenfold—from 300,000 people to 2.2 million people today—and 1 out of 5 people incarcerated are serving time for a drug offense.2 People of color have disproportionately felt the damaging and unnecessary consequences of these outdated tough-on-crime policies. Members of these communities have been sentenced to long terms of imprisonment as well as lifetimes of poverty and economic insecurity.3 According to the Drug Policy Alliance, drug enforcement in the United States is rooted in racial discrimination, as the first anti-drug laws were established around the turn of the 20th century and targeted Chinese immigrants, black Americans, and Mexican migrants.4 Today, between 40 percent and 50 percent of all drug arrests are for mari- juana.5 Discriminatory enforcement of marijuana laws is one reason that black and Latino Americans make up two-thirds of the U.S. prison population despite only comprising 12 percent and 17 percent of the U.S. -
Adapting a Regulatory Framework for the Emerging Cannabis Industry
OCTOBER 2019 Learn more about NCIA’s Policy Council TheCannabisIndustry.org/PolicyCouncil National Cannabis Industry Association TheCannabisIndustry.org ADAPTING A REGULATORY FRAMEWORK FOR THE EMERGING CANNABIS INDUSTRY National Cannabis Industry Association (NCIA) Adapting a Proven Regulatory Framework for the Emerging Cannabis Industry Table of Contents 1 EXECUTIVE SUMMARY 8 INTRODUCTION 11 LEGAL STATE OF CANNABIS IN THE UNITED STATES 13 CURRENT LEGISLATIVE EFFORTS 14 CANNABIS PRODUCTS 15 REMOVING THE OUTDATED REGULATORY STRUCTURE 16 ESTABLISHING A NEW REGULATORY FRAMEWORK 19 SOCIAL EQUITY 20 LANE #1: Pharmaceutical Drugs 23 LANE #2: Ingested, Inhaled, or Topically Applied THC Products 31 LANE #3: Ingested and Inhaled Cannabinoid Products with Low/No THC 40 LANE #4: Topically Applied Low THC Products 43 CONCLUSION National Cannabis Industry Association (NCIA) Adapting a Proven Regulatory Framework for the Emerging Cannabis Industry Executive Summary For almost a century, the United States government has criminalized the production, distribution, and sale of cannabis. However, this era of prohibition has been crumbling in the face of voter and, increasingly, legislative revolt. Even as these federal laws remain unchanged, most states have legalized some form of medical cannabis, and eleven states and the District of Columbia have changed their laws to regulate adult-use cannabis in a manner similar to alcohol. Moreover, Congress recently removed hemp (and any cannabinoids derived therefrom) from the Controlled Substances Act (CSA), legalizing -
Marijuana Legalization Has Gained Traction in Recent Years in the United
How One 11-Page Bill Could Yield Billions in Annual Benefits: The Marijuana Justice Act of 2017 Haley Dunn arijuana legalization has gained traction in recent years in the United States with a variety of bipartisan supporters. Primary benefits often cited include savings in enforcement and incarceration costs, additional tax revenue and jobs, release and expungement for those incarcerated, Mand lowered racial and economic disproportionality in the U.S. criminal justice system. Critics often bring up health costs, increases in impaired driving, harmful effects on adolescent brain development, and greater attendant crime as possible drawbacks. This article examines the potential costs and benefits of federal marijuana legalization under the Senate version of the Marijuana Justice Act of 2017 (S. 1689) introduced in the 115th Congress, assuming 30 additional states legalize recreational marijuana and set up a regulated commercial retail system. Using an analysis that operates under a net present value over 1,000 years and reflects 2017 dollar amounts, the results are overwhelming: these combined efforts could lead to nationwide lifetime net benefits of over $168 billion, with approximately $50 billion in the first year alone, and $17 billion in tax revenue that federal and state governments could receive annually. This article also runs best- and worst-case scenario sensitivity analyses in a post- enactment universe—best being one in which all 50 states legalize recreational marijuana and worst being one in which no additional states legalize. Even the worst- case scenario would lead to lifetime net benefits of over $77 billion ($4 billion/year) and, in the best case, over $1.4 trillion ($75 billion/year). -
Marijuana Law Reform in 2020 and Beyond: Where We Are and Where We’Re Going
Marijuana Law Reform in 2020 and Beyond: Where We Are and Where We’re Going Sam Kamin* INTRODUCTION 2016 was supposed to be a tipping point for marijuana legalization in the United States. Hillary Clinton was a huge favorite to win the presidency and, despite her lukewarm stance on marijuana law reform,1 many were predicting that the federal ban on marijuana would end during her first term in office. The unexpected election of Donald Trump changed all of that. Marijuana activists came to fear not just that fundamental change in the nation’s marijuana laws would stall with Trump as president but that he might bring a significant, perhaps permanent, reversal of the building momentum toward marijuana legalization in the United States.2 To the surprise of many, however, the last four years have seen continued expansion of marijuana law reform at both the state and federal levels. The federal prohibition of marijuana has shown its first cracks, and * Professor of Law, University of Denver, Sturm College of Law. J.D., PhD, University of California, Berkeley; B.A., Amherst College. Thanks to the participants at Seattle University for their comments and questions and to the editors on the Law Review for their diligent work on this piece. 1. See German Lopez, Democratic Voters Love Marijuana Legalization. Hillary Clinton Doesn’t., VOX (June 13, 2015), https://www.vox.com/2015/4/13/8393495/hillary-clinton-marijuana- legalization [https://perma.cc/L2RC-CQC8] (“Hillary Clinton’s approach to marijuana legalization can best be described as a cautious, leave-it-to-the-states strategy similar to that of the Obama administration. -
New Federal Paradigm in Marijuana Legalization
MARIJUANA Issue Brief JANUARY 16, 2018 “It is one of the happy incidents of the federal system that a single courageous State may, if its citizens choose, serve as a laboratory; and try novel social and economic experiments without risk to the rest of the country.” – Justice Louis Brandeis (1932)1 New Federal Paradigm In Marijuana Legalization Introduction Conflicting activities related to marijuana at state and federal levels raise questions as to whether a new federal/state legal relationship concerning marijuana legalization is forthcoming. The Network for Public Health Law has been tracking state laws concerning marijuana since its inception.2 In 2017, West Virginia joined twenty-eight other states and D.C. in allowing residents to use marijuana for medicinal purposes. Eight states legally authorize and regulate recreational marijuana programs subject to state taxation for various public purposes.3 In January 2018, Vermont lawmakers approved legislation to legalize recreational marijuana, which the state’s Governor Phil Scott has promised to sign.4 Despite drastic expansion of marijuana legalization throughout U.S. states in recent years, federal guidance issued in January 2018 is at odds with this movement, imparting legal uncertainty on the future of the marijuana industry. This Issue Brief reviews the current federal legal framework regarding marijuana control and explores possible options for federal, state, and local governments in the near future. As the concepts of federalism in public health law and criminal law continue to evolve, activity at the state level will play a large role in the formulation of marijuana laws and public policy. In tandem with marijuana legalization in states, social and public health impacts of these policies should be considered, especially regarding potential social determinants of health and health inequalities. -
Federal Law California Law
WHAT PROVIDERS BY NATALIA MAZINA NEED TO KNOW OF-COUNSEL AT KLEIN, HOCKEL, IEZZA & PATEL, P.C. ABOUT MARIJUANA [email protected] 415-802-4057 legal perspective FEDERAL LAW CALIFORNIA LAW SCHEDULE I: Cal Compassionate Use Act (CUA) (1996) (amended by SB 420) in • Has a high potential for abuse 2003: • Has no currently accepted medical Legalized for treatment of many medical conditions (including use HIV/AIDS) and “any other illness for which marijuana provides • Lack of accepted safety relief” (open to broad interpretation) Removes state penalties for use, possession or growth with a No prescription may be written for Sch. I physician’s recommendation. drug, and such substances are subject to Unlike other medications, providers do not prescribe amount, production quotas by the DEA number of refills, content of medication or route of administration (dispensary’s function). “’[M]arihuana’ means all parts of the plant Cannabis sativa L., whether growing or not; Adult Use of Marijuana Act (AUMA) 2016 the seeds thereof; the resin extracted from any part of such plant; and every • Adults over 21 can possess, transport, purchase, consume and compound, manufacture, salt, derivative, share up to 1oz of non-medical marijuana and 8 grams of mixture, or preparation of such plant, its concentrates. Allows to grow up to 6 plants for personal use. seeds or resin.” • Designates Department of consumer affairs as the lead 21 USC § 802(16) regulatory agency. Local control provisions • Requires state agencies begin issuing licenses by Jan. 1, 2018 Gonzales v. Raich, 545 U.S. 1 (2005): Marijuana users and growers in California Conflict between medical and recreational laws, Med. -
The STATES Act: a Response to the Rescission of the Cole Memo
196 REVIEW OF BANKING & FINANCIAL LAW VOL. 38 XV. The STATES Act: A Response to the Rescission of the Cole Memo A. Introduction As of the summer of 2018, nine states have decriminalized the recreational use of marijuana and thirty permit medicinal use.1 Several other states have some form of pending legislation that will further expand the legal cannabis industry.2 However, cannabis remains illegal under the federal Controlled Substances Act (CSA).3 This presents a number of problems for cannabis-based companies and any financial services providers who wish to do business with them. On October 19, 2009, then-Deputy Attorney General David Ogden published what is known as the Ogden Memo.4 The Ogden Memo directed U.S. Attorneys away from enforcement of the CSA against medical cannabis businesses. 5 The Attorney General was concerned with public perception of actions against the sick and elderly. 6 The Ogden Memo was followed by the Cole Memo on August 29, 2013.7 The Cole Memo established new priorities for the 1 Matt Laslo, Elizabeth Warren: Jeff Sessions Acted as Catalyst for Weed Legalization, ROLLING STONE (Aug. 27, 2018. 12:35 PM), https://www. rollingstone.com/culture/culture-features/elizabeth-warren-jeff-sessions- weed-legalization-states-act-715651 [https://perma.cc/LVN7-3VAZ]. 2 Kris Krane, At the Ballot Box: These Four States Could Legalize Some Form of Marijuana in November, FORBES (Aug. 21, 2018, 6:6 AM), https://www.forbes.com/sites/kriskrane/2018/08/21/at-the-ballot-box-these- four-states-could-legalize-some-form-of-marijuana-in-november/#32405b1f5 c95 [https://perma.cc/GWP4-2NTT]. -
Emerging Issues with Marijuana Legalization
Emerging Issues With Marijuana Legalization Faye Caldwell Email: [email protected] Disclaimer: no Legal advice or attorney-client relationship This presentation has been prepared by Caldwell Everson, PLLC for informational purposes only. The information presented does not constitute legal advice and is not to be acted on as such. This information is not intended to create, and receipt of it does not establish an attorney-client relationship. By participating in this presentation you are not and do not become a client of Caldwell Everson PLLC. Any information contained herein is not intended as a substitute for legal counsel. You should not rely upon any information contained in this presentation without seeking legal advice from an attorney of your choice and who practices law in your state. © Caldwell Everson PLLC 2 As of November 29, 2018: 33 states + D.C. + 2 U.S. territories (Guam, PR) have passed Comprehensive “Medical marijuana” Laws Laws vary widely 13 other states have passed low THC/High CBD laws All passed since 2014 in mostly southern states after CNN documentary Some states with comprehensive medical marijuana laws also have CBD laws 10 states + D.C. + 1 U.S. territory (CNMI) have passed recreational marijuana laws All except US territory also had comprehensive medical marijuana laws 4 states prohibit marijuana for all purposes © Caldwell Everson PLLC (Idaho, Kansas, Nebraska, South Dakota) 3 State Medical Marijuana Laws 33 states + D.C. Alaska (1998) Maine (1999) New York (2014) Arizona (2010) Maryland (2014) North Dakota (2016) Arkansas (2016) Massachusetts (2012) Ohio (2016) California (1996) Michigan (2008) Oklahoma (2018) Colorado (2000) Minnesota (2014) Oregon (1998) Connecticut (2012) Missouri (2018) Pennsylvania (2016) Delaware (2011) Montana (2004) Rhode Island (2006) Florida (2016) Nevada (2000) Utah (2018) Hawaii (2000) New Hampshire (2013) Vermont (2004) Illinois (2013) New Jersey (2010) Washington (1998) Louisiana (2015) New Mexico (2007) West Virginia (2017) Washington, D.C. -
Update: Federal Legislation Related to Cannabis
Update on Federal Legislation Related to Cannabis House Commerce & Gaming Committee March 26, 2021 Presented by Peter Clodfelter, Counsel, House Office of Program Research 1 1. Marijuana Opportunity Reinvestment and Expungement Act of 2020 (“MORE Act of 2020”) 2. Strengthening the Tenth Amendment Through Entrusting States Act (“STATES Act”) (2019) Scope of 3. Regulate Marijuana Like Alcohol Act (2019) Presentation 4. Marijuana 1-to-3 Act of 2021 5. Secure And Fair Enforcement Banking Act of 2019 (“SAFE Banking Act of 2019”) 6. Cannabidiol and Marijuana Research Expansion Act (2019, 2021) 2 Background: The Five Schedules Under the Federal CSA • Schedule I: No currently accepted medical use and a high potential for abuse ➢ Marihuana (cannabis), heroin, LSD, ecstasy, and peyote • Schedule II: High potential for abuse, with use potentially leading to severe psychological or physical dependence ➢ Vicodin, cocaine, methamphetamine, oxycodone (OxyContin), fentanyl, and Adderall • Schedule III: Moderate to low potential for physical and psychological dependence ➢ Tylenol with codeine, ketamine, anabolic steroids, and testosterone • Schedule IV: Low potential for abuse and low risk of dependence ➢ Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol • Schedule V: Lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics ➢ Robitussin AC, Lomotil, Motofen, Lyrica, Parepectolin 3 1. Introduced in House and Senate: ➢H.R. 3884 (Rep. Nadler-NY) (2019) ➢S. 2227 (Sen. Harris-CA) (2019) Marijuana 2. “AN ACT To decriminalize and deschedule Opportunity cannabis, to provide for reinvestment in Reinvestment certain persons adversely impacted by the War on Drugs, to provide for expungement and of certain cannabis offenses, and for other Expungement purposes” Act of 2020 3.